Wells Fargo’s ENVUE MEDICAL INC NEW FEED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23 Hold
4
﹤0.01% 6907
2026
Q1
$107 Buy
+4
New +$104 ﹤0.01% 6495
2024
Q2
Hold
0
-$14 7264
2024
Q1
Hold
0
7219
2023
Q4
Hold
0
7296
2023
Q3
Hold
0
7140
2023
Q2
Hold
0
7105
2023
Q1
Hold
0
7188
2022
Q4
Hold
0
7024
2022
Q3
Hold
0
7119
2022
Q2
Hold
0
7249
2022
Q1
Hold
0
6588
2021
Q4
Hold
0
7609
2021
Q3
Hold
0
7323
2021
Q2
Hold
0
7250
2021
Q1
Hold
0
7204
2020
Q4
Hold
0
6822
2020
Q3
Hold
0
6692
2020
Q2
Hold
0
6633
2020
Q1
Hold
0
6588

Other funds holding FEED

Wells Fargo's FEED Position: Q2 2026 in Review

Wells Fargo held its ENVUE MEDICAL INC NEW (FEED) position steady in Q2 2026 at 4 shares worth $23. The position accounts for ﹤0.01% of the portfolio, ranked #6907.

Wells Fargo first reported a position in FEED in Q1 2026 and has held it in 2 quarters since. The position peaked at $107 in Q1 2026. 12 funds tracked by Wall St. Rank hold FEED as of Q2 2026.

  • Wells Fargo held 4 shares of ENVUE MEDICAL INC NEW worth $23 as of Q2 2026.
  • Wells Fargo left its ENVUE MEDICAL INC NEW share count unchanged in Q2 2026.
  • ENVUE MEDICAL INC NEW made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6907 holding.
  • Wells Fargo first reported a position in ENVUE MEDICAL INC NEW in Q1 2026 and has held it in 2 quarters since.
  • Wells Fargo's ENVUE MEDICAL INC NEW position peaked at $107 in Q1 2026.
  • 12 funds tracked by Wall St. Rank held ENVUE MEDICAL INC NEW as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.